{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:46:29Z","timestamp":1784547989831,"version":"3.55.0"},"reference-count":22,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,5,22]],"date-time":"2006-05-22T00:00:00Z","timestamp":1148256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Photoderm Photoimm Photomed"],"published-print":{"date-parts":[[2006,6]]},"abstract":"<jats:p><jats:bold>Background: <\/jats:bold> Narrow band (NB)\u2010UVB has been used in the treatment of vitiligo for years but statistical evaluation of the clinical response in both segmental and non\u2010segmental vitiligo patients has yet to be assessed.<\/jats:p><jats:p><jats:bold>Objectives: <\/jats:bold> Statistical evaluation of the clinical response of vitiligo patients to NB\u2010UVB in both segmental and non\u2010segmental types affecting different body sites.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> This study included 150 patients with vitiligo either segmental (10%) or non\u2010segmental (90%). NB\u2010UVB therapy was given twice weekly till reaching our end point of 100% re\u2010pigmentation or a cut point in unresponsive cases. Evaluation of the percentage of re\u2010pigmentation was performed by total body photography and planimetry every 8 weeks.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> The overall response to therapy in the non\u2010segmental vitiligo group demonstrated that 48% of the patients showed marked response, 27% showed moderate response and 25% showed mild response after UVB therapy. The patients showed marked response in 76.3% in face lesions, 41.9% in trunk lesions and 37.6% in limbs lesions. None of the patients in the acral areas achieved marked response. The mean duration of therapy was 7.8 months. Moreover, the results demonstrated that the earlier the patient was treated, the better the response was especially for lesions on the face, trunk and limbs. On the other hand, in the segmental vitiligo group, patients showed no more than mild response to NB\u2010UVB whatever the site of the lesion was. No side effects were encountered with NB\u2010UVB therapy except for aggravation of the disease in two cases and erythema in one patient who was an outdoor worker and was skin type II.<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold> The type of vitiligo, the affected anatomical area and the disease duration are important factors that influence potential re\u2010pigmentation.<\/jats:p>","DOI":"10.1111\/j.1600-0781.2006.00222.x","type":"journal-article","created":{"date-parts":[[2006,5,22]],"date-time":"2006-05-22T14:50:25Z","timestamp":1148309425000},"page":"157-163","source":"Crossref","is-referenced-by-count":106,"title":["Evaluation of the effects of NB\u2010UVB in both segmental and non\u2010segmental vitiligo affecting different body sites"],"prefix":"10.1111","volume":"22","author":[{"given":"T. S.","family":"Anbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Westerhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. T.","family":"Abdel\u2010Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"El\u2010 Khayyat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,5,22]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"513","volume-title":"The pigmentary system: physiology and pathophysiology","author":"Nordlund JJ","year":"1998"},{"key":"e_1_2_6_3_2","first-page":"167","article-title":"Vitiligo","volume":"2","author":"Njoo MD","year":"2001","journal-title":"pathogenesis and treatment"},{"key":"e_1_2_6_4_2","first-page":"671","article-title":"Segmental vitiligo","volume":"35","author":"Hann SK","year":"1996","journal-title":"clinical findings in 208 patients"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890480045006"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70149-2"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90133-6"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0926-9959.2001.00290.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1974.tb13086.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archderm.1976.01630350007002","article-title":"Photochemotherapy of vitiligo","volume":"112","author":"Parrish JA","year":"1976","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-9272-3"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1988.01670110016003"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1001\/archderm.1988.01670110009002","article-title":"Treatment of localized vitiligo by autologous minigrafting","volume":"124","author":"Falabella R.","year":"1988","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_14_2","first-page":"990","article-title":"Repigmentation in vitiligo vulgaris by autologous minigrafting","volume":"33","author":"Boersma BR","year":"1995","journal-title":"results in nineteen patients"},{"key":"e_1_2_6_15_2","first-page":"270","article-title":"An open randomized study of treatment of 39 patients of generalized vitiligo with narrow\u2010band UVB versus topical calcipotriol+PUVA versus PUVA therapy for 6\u201312 months","volume":"16","author":"Rubaie SAI.","year":"2002","journal-title":"J Eur Acad Derm Venereol Supplement"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12480997"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.12.1514"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0749.2003.00070.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1998.00557.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.1999.tb00861.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.114752"},{"key":"e_1_2_6_22_2","first-page":"1532","article-title":"Nonsurgical re \u2013 pigmentation therapies in vitiligo","volume":"134","author":"Njoo MD","year":"1998","journal-title":"meta \u2013 analysis of the literature"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)01484-1"}],"container-title":["Photodermatology, Photoimmunology &amp; Photomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0781.2006.00222.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0781.2006.00222.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T22:08:50Z","timestamp":1697062130000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0781.2006.00222.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,22]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1111\/j.1600-0781.2006.00222.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0781.2006.00222.x","archive":["Portico"],"relation":{},"ISSN":["0905-4383","1600-0781"],"issn-type":[{"value":"0905-4383","type":"print"},{"value":"1600-0781","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,22]]}}}